Preliminary results of the UK Medical Research Council trial in chronic lymphocytic leukaemia - CLL3

Preliminary results of the UK Medical Research Council trial in chronic lymphocytic leukaemia - CLL3

Bibliografski detalji
Glavni autori:	Catovsky, D, Hamblin, T, Richards, S, Leukaemia, M
Format:	Journal article
Izdano:	1998

Slični predmeti

UK Medical Research Council CLL3 - A randomized trial of the addition of epirubicin to standard chlorambucil treatment.
od: Catovsky, D, i dr.
Izdano: (2000)

Collaborative meta-analysis of randomised trials in chronic lymphocytic leukaemia (CLL)
od: Binet, J, i dr.
Izdano: (1998)

Patients' experience of chronic lymphocytic leukaemia: baseline health-related quality of life results from the LRF CLL4 trial.
od: Else, M, i dr.
Izdano: (2008)

Predictors of infection in chronic lymphocytic leukaemia (CLL).
od: Griffiths, H, i dr.
Izdano: (1992)

The combination of fludarabine and cyclophosphamide has a beneficial effect on the incidence of hemolytic anemia in chronic lymphocytic leukemia. Results from the UK LRF CLL4 trial
od: Dearden, C, i dr.
Izdano: (2007)

Prognostic factors in chronic lymphocytic leukaemia: the importance of age, sex and response to treatment in survival. A report from the MRC CLL 1 trial. MRC Working Party on Leukaemia in Adults.
od: Catovsky, D, i dr.
Izdano: (1989)

Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial.
od: Catovsky, D, i dr.
Izdano: (2007)

Quality of life in chronic lymphocytic leukemia: 5-year results from the multicenter randomized LRF CLL4 trial.
od: Else, M, i dr.
Izdano: (2012)

Early results from LRF CLL4: A UK multicenter randomized trial
od: Catovsky, D, i dr.
Izdano: (2005)

Intensification of treatment and survival in all children with lymphoblastic leukaemia: results of UK Medical Research Council trial UKALL X. Medical Research Council Working Party on Childhood Leukaemia.
od: Chessells, J, i dr.
Izdano: (1995)

Results of Medical Research Council Childhood Leukaemia Trial UKALL VIII (report to the Medical Research Council on behalf of the Working Party on Leukaemia in Childhood).
od: Eden, O, i dr.
Izdano: (1991)

Intensification of treatment for adults with acute lymphoblastic leukaemia: results of U.K. Medical Research Council randomized trial UKALL XA. Medical Research Council Working Party on Leukaemia in Adults.
od: Durrant, I, i dr.
Izdano: (1997)

A comparison of oral and intravenous fludarabine in the LRF CLL4 trial (on behalf of the UKNCRI CLL trials group)
od: Hillmen, P, i dr.
Izdano: (2006)

Quality of life in the UK LRF CLL4 trial (on behalf of the UKNCRI CLL Trials Group)
od: Else, M, i dr.
Izdano: (2006)

A comparison of the efficacy and safety of oral and intravenous fludarabine in chronic lymphocytic leukemia in the LRF CLL4 trial.
od: Dearden, C, i dr.
Izdano: (2011)

UK Medical Research Council randomised, multicentre trial of interferon-alpha n1 for chronic myeloid leukaemia: improved survival irrespective of cytogenetic response. The UK Medical Research Council's Working Parties for Therapeutic Trials in Adult Leukaemia.
od: Allan, N, i dr.
Izdano: (1995)

Results of Medical Research Council trial UKALL IX in acute lymphoblastic leukaemia in adults: report from the Medical Research Council Working Party on Adult Leukaemia.
od: Durrant, I, i dr.
Izdano: (1993)

Drug sensitivity by TRAC (DISC) assay as a prognostic factor for patient response in untreated CLL: Results from the UK LRF CLL4 trial.
od: Bosanquet, A, i dr.
Izdano: (2006)

Prognostic factors in the UK LRF CLL4 trial
od: Oscier, D, i dr.
Izdano: (2006)

Mutational status of the TP53 gene as a predictor of response and survival in patients with chronic lymphocytic leukemia: results from the LRF CLL4 trial.
od: Gonzalez, D, i dr.
Izdano: (2011)

Response to therapy and survival in CLL is influenced by genetic markers. preliminary analysis from the LRF CLL4 trial.
od: Catovsky, D, i dr.
Izdano: (2004)

Prognostic factors in the UK LRF CLL4 trial.
od: Oscier, D, i dr.
Izdano: (2006)

Prognostic factors in the UK LRF CLL4 trial.
od: Oscier, D, i dr.
Izdano: (2005)

The Medical Research Council trials in adult acute lymphocytic leukemia.
od: Durrant, I, i dr.
Izdano: (2000)

Benefit of dexamethasone compared with prednisolone for childhood acute lymphoblastic leukaemia: results of the UK Medical Research Council ALL97 randomized trial.
od: Mitchell, C, i dr.
Izdano: (2005)

Chemotherapeutic options in chronic lymphocytic leukemia: a meta-analysis of the randomized trials. CLL Trialists' Collaborative Group.
od: Richards, S
Izdano: (1999)

The lack of survival differences in randomised trials in CLL may be related to the effect of second line therapies. A report from the LRF CLL4 trial.
od: Catovsky, D, i dr.
Izdano: (2006)

Quality of life in the LRF CLL4 trial.
od: Else, M, i dr.
Izdano: (2005)

Comparison of oral and intravenous fludarabine in the LRF CLL4 trial.
od: Hillmen, P, i dr.
Izdano: (2005)

Analysis of the immunophenotype of children treated on the Medical Research Council United Kingdom Acute Lymphoblastic Leukaemia Trial XI (MRC UKALLXI). Medical Research Council Childhood Leukaemia Working Party.
od: Hann, I, i dr.
Izdano: (1998)

Cytogenetics and prognosis in childhood lymphoblastic leukaemia: results of MRC UKALL X. Medical Research Council Working Party in Childhood Leukaemia.
od: Chessels, J, i dr.
Izdano: (1997)

Thioguanine compared with mercaptopurine in childhood lymphoblastic leukaemia: Results of the United Kingdom medical research council randomised trial ALL97.
od: Lennard, L, i dr.
Izdano: (2005)

Ofatumumab in advanced stage chronic lymphocytic leukaemia: results of the UK named patient compassionate use programme.
od: Chowdhury, O, i dr.
Izdano: (2011)

Failure of a new protocol to improve treatment results in paediatric lymphoblastic leukaemia: lessons from the UK Medical Research Council trials UKALL X and UKALL XI.
od: Chessells, J, i dr.
Izdano: (2002)

Alemtuzumab in combination with methylprednisolone is a highly effective induction regimen for patients with chronic lymphocytic leukemia and deletion of TP53: final results of the national cancer research institute CLL206 trial.
od: Pettitt, A, i dr.
Izdano: (2012)

Immunoglobulin replacement in chronic lymphocytic leukaemia.
od: Bunch, C
Izdano: (1988)

Improved survival with early intensification: combined results from the Medical Research Council childhood ALL randomised trials, UKALL X and UKALL XI. Medical Research Council Working Party on Childhood Leukaemia.
od: Richards, S, i dr.
Izdano: (1998)

Medical Research Council leukaemia trial--UKALL V: an attempt to reduce the immunosuppressive effects of therapy in childhood acute lymphoblastic leukemia. Report to the Council by the Working Party on Leukaemia in Childhood.
od: Chessells, J, i dr.
Izdano: (1986)

Incidence and Outcome of Osteonecrosis in Children and Young Adults with Acute Lymphoblastic Leukaemia Treated on a Dexamethasone Containing Protocol: Results of the Medical Research Council UK Trial ALL 2003
od: Vora, A, i dr.
Izdano: (2008)

Acute lymphoblastic leukaemia in infancy: experience in MRC UKALL trials. Report from the Medical Research Council Working Party on Childhood Leukaemia.
od: Chessells, J, i dr.
Izdano: (1994)